Citi cuts EyePoint price target to $17 from $35, keeps Buy, stock down 67%
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz lowered his price target on EyePoint Pharmaceuticals (NASDAQ: EYPT) to $17.00 from $35.00, while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
